Back to top
more

Chemed (CHE)

(Delayed Data from NYSE)

$560.42 USD

560.42
102,417

-12.92 (-2.25%)

Updated Apr 26, 2024 04:00 PM ET

After-Market: $559.92 -0.50 (-0.09%) 6:30 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value A Growth A Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 37% (93 out of 252)

Industry: Medical - Outpatient and Home Healthcare

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for CHE

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for Chemed Corporation falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 264 74 33 163 6
Receivables 182 139 137 127 144
Notes Receivable 0 0 0 0 0
Inventories 12 10 10 7 7
Other Current Assets 43 49 50 33 33
Total Current Assets 501 273 230 329 191
Net Property & Equipment 204 200 194 188 176
Investments & Advances 106 93 99 89 77
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 675 681 687 697 704
Deposits & Other Assets 56 60 8 9 9
Total Assets 1,668 1,442 1,343 1,435 1,268
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 64 42 73 54 51
Current Portion Long-Term Debt 0 5 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 153 150 152 157 128
Income Taxes Payable 7 0 0 9 0
Other Current Liabilities 49 61 39 43 44
Total Current Liabilities 312 297 302 299 262
Mortgages 0 0 0 0 0
Deferred Taxes/Income 134 131 122 109 95
Convertible Debt 0 0 0 0 0
Long-Term Debt 0 93 185 0 90
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 13 12 10 26 8
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 560 643 719 534 542
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 37 37 37 36 36
Capital Surplus 1,341 1,150 1,044 961 861
Retained Earnings 2,447 2,198 1,970 1,724 1,426
Other Equity 2 2 2 2 2
Treasury Stock 2,720 2,588 2,430 1,823 1,598
Total Shareholder's Equity 1,108 799 623 901 727
Total Liabilities & Shareholder's Equity 1,668 1,442 1,343 1,435 1,268
Total Common Equity 1,108 799 623 901 727
Shares Outstanding 15.06 14.87 15.70 15.90 16.00
Book Value Per Share 73.56 53.71 39.70 56.68 45.41

Fiscal Year End for Chemed Corporation falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 264 173 160 58
Receivables NA 182 168 120 154
Notes Receivable NA 0 0 0 0
Inventories NA 12 13 12 11
Other Current Assets NA 43 41 45 40
Total Current Assets NA 501 395 337 262
Net Property & Equipment NA 204 205 208 204
Investments & Advances NA 106 104 100 97
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 0 0 0 0
Intangibles NA 675 678 676 679
Deposits & Other Assets NA 56 57 57 58
Total Assets NA 1,668 1,562 1,505 1,431
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA 0 0 0 0
Accounts Payable NA 64 57 41 40
Current Portion Long-Term Debt NA 0 0 0 5
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 153 143 138 119
Income Taxes Payable NA 7 5 0 11
Other Current Liabilities NA 49 55 85 69
Total Current Liabilities NA 312 297 302 283
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 134 133 136 133
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 0 0 0 16
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 13 13 13
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 560 543 553 551
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 37 37 37 37
Capital Surplus NA 1,341 1,254 1,240 1,186
Retained Earnings NA 2,447 2,363 2,294 2,246
Other Equity NA 2 2 2 2
Treasury Stock NA 2,720 2,637 2,622 2,592
Total Shareholder's Equity NA 1,108 1,019 952 880
Total Liabilities & Shareholder's Equity NA 1,668 1,562 1,505 1,431
Total Common Equity 0 1,108 1,019 952 880
Shares Outstanding 15.12 15.06 15.00 15.00 15.00
Book Value Per Share 0.00 73.56 67.95 63.47 58.67